Enlivex Therapeutics (ENLV) stock forecast for 2022 – 2027

Are you interested in Enlivex Therapeutics Ltd. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ENLV stock price in 2022-2027. Is ENLV a good long term stock? When should I take profit in Enlivex Therapeutics stock? Buy or sell stock? Will ENLV stock price go up? What are analysts’ forecasts for ENLV stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ENLV stock returns are also predicted based on historical data.

According to our research, ENLV stock is a bad long-term investment. ENLV share price has been in a bull cycle for the past year. Enlivex Therapeutics Ltd. stock trend is positive.

Enlivex Therapeutics company info

Industry Biotechnology
Address 14 Einstein Street, Ness Ziona, 7403618, Israel
Website https://www.enlivex.com

Forecasting

52 Week High: 12.5275 USD
52 Week Low: 0.5742 USD
1 Year Forecast: 5.23382 USD
5 Year Forecast: 7.82628 USD

Agilent Technologies info

Market Cap: 98.14M
52 Week Change: -7.634%
52 Week High: 29.4 USD
52 Week Low: 5.63 USD
Beta: 1.47848
50 Day Moving Average: 6.42
90 Day Moving Average: 7.575
200 Day Moving Average: 8.66
Resistance Level: 23.9976
Pivot Point: 8.8209
Support Level: -9.4149
Enterprise Value: 30,540,702
Forward P/E: 0
Forward EPS: -1.54
Profit Margin: 0.00%
Shares Outstanding: 18,330,500
EBITDA: -2.08
Held Percent Institutions: 12.38%
PEG Ratio (5Y): 0
Trailing EPS: -0.92

Enlivex Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Enlivex Therapeutics Stock Forecast for 2022

March 2022 7.07 1.01 -85.71%
April 2022 0.99 1.01 2.02%
May 2022 2.94 2.94 0%
June 2022 2.94 4.95 68.37%
July 2022 6.06 5 -17.49%
August 2022 6.86 9.18 33.82%
September 2022 7.84 8.16 4.08%
October 2022 9.18 6.06 -33.99%
November 2022 4.95 3.96 -20%
December 2022 3.06 2.97 -2.94%

Enlivex Therapeutics Stock Forecast for 2023

January 2023 4.9 7 42.86%
February 2023 7.92 8.16 3.03%
March 2023 8 1.98 -75.25%
April 2023 3.96 1.98 -50%
May 2023 3.92 4 2.04%
June 2023 2.97 5.94 100%
July 2023 9.09 7.92 -12.87%
August 2023 6.86 8.82 28.57%
September 2023 9.09 9 -0.99%
October 2023 10.1 6 -40.59%
November 2023 6.06 3.92 -35.31%
December 2023 3.92 4.08 4.08%

Enlivex Therapeutics Stock Forecast for 2024

January 2024 6.12 8 30.72%
February 2024 8 8 0%
March 2024 7.84 2.97 -62.12%
April 2024 4.95 4.08 -17.58%
May 2024 3.92 4.04 3.06%
June 2024 6.12 7 14.38%
July 2024 9.18 8 -12.85%
August 2024 7.07 10.1 42.86%
September 2024 11.88 11.11 -6.48%
October 2024 10 6 -40%
November 2024 5.88 5 -14.97%
December 2024 6.93 5.88 -15.15%

Enlivex Therapeutics Stock Forecast for 2025

January 2025 6.12 8 30.72%
February 2025 11 9.09 -17.36%
March 2025 10 5.88 -41.2%
April 2025 5 4.95 -1%
May 2025 4.08 4.9 20.1%
June 2025 7.14 9.8 37.25%
July 2025 9 7.84 -12.89%
August 2025 8 9.9 23.75%
September 2025 11.88 11.11 -6.48%
October 2025 11.11 6.93 -37.62%
November 2025 8.91 5.94 -33.33%
December 2025 8.08 6.86 -15.1%

Enlivex Therapeutics Stock Forecast for 2026

January 2026 6 8.82 47%
February 2026 12 9.9 -17.5%
March 2026 11.22 6.12 -45.45%
April 2026 6 5 -16.67%
May 2026 5 5.88 17.6%
June 2026 8.16 10 22.55%
July 2026 9.9 9.09 -8.18%
August 2026 11 13.26 20.55%
September 2026 12 11.88 -1%
October 2026 11.11 8.08 -27.27%
November 2026 10.1 7.92 -21.58%
December 2026 6.93 6.86 -1.01%

Enlivex Therapeutics Stock Forecast for 2027

January 2027 6.86 7.07 3.06%